Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Life Sciences

formerly Central European Journal of Biology

Editor-in-Chief: Ratajczak, Mariusz

IMPACT FACTOR 2018: 0.504
5-year IMPACT FACTOR: 0.583

CiteScore 2018: 0.63

SCImago Journal Rank (SJR) 2018: 0.266
Source Normalized Impact per Paper (SNIP) 2018: 0.311

ICV 2017: 154.48

Open Access
See all formats and pricing
More options …
Volume 9, Issue 7


Volume 10 (2015)

The action of CGRP and SP on cultured skin fibroblasts

Bernardo Hochman
  • Plastic Surgery Division, Department of Surgery, Postgraduate Program in Translational Surgery, Universidade Federal de São Paulo (Unifesp), 04024-002, São Paulo/SP, Brazil
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Vanina Tucci-Viegas
  • Plastic Surgery Division, Department of Surgery, Postgraduate Program in Translational Surgery, Universidade Federal de São Paulo (Unifesp), 04024-002, São Paulo/SP, Brazil
  • Department of Agricultural and Environmental Sciences, Universidade Estadual de Santa Cruz (UESC), 45662-900, Ilhéus/BA, Brazil
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Paola Monteiro
  • Plastic Surgery Division, Department of Surgery, Postgraduate Program in Translational Surgery, Universidade Federal de São Paulo (Unifesp), 04024-002, São Paulo/SP, Brazil
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jerônimo França / Silvana Gaiba
  • Plastic Surgery Division, Department of Surgery, Postgraduate Program in Translational Surgery, Universidade Federal de São Paulo (Unifesp), 04024-002, São Paulo/SP, Brazil
  • Department of Biological Sciences, Universidade Estadual de Santa Cruz (UESC), 45662-900, Ilhéus/BA, Brazil
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lydia Ferreira
  • Plastic Surgery Division, Department of Surgery, Postgraduate Program in Translational Surgery, Universidade Federal de São Paulo (Unifesp), 04024-002, São Paulo/SP, Brazil
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-04-30 | DOI: https://doi.org/10.2478/s11535-014-0301-6
  • [1] Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol. 1998; 30:5–11. http://dx.doi.org/10.1016/S0306-3623(97)00078-5CrossrefGoogle Scholar

  • [2] Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview. Eur J Dermatol. 1998; 8:299–306. Google Scholar

  • [3] Watson RE, Supowit SC, Zhao H, Katki KA, Dipette DJ. Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res. 2002; 35:1033–1045. http://dx.doi.org/10.1590/S0100-879X2002000900004CrossrefGoogle Scholar

  • [4] Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy. 1997; 27:284–295. http://dx.doi.org/10.1046/j.1365-2222.1997.d01-502.xCrossrefGoogle Scholar

  • [5] Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, Petersen LJ, Schmelz M. Acute effects of substance P and calcitonin generelated peptide in human skin—a microdialysis study. J Invest Dermatol. 2000; 115:1015–1020. http://dx.doi.org/10.1046/j.1523-1747.2000.00142.xCrossrefGoogle Scholar

  • [6] Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology. 2003; 206:17–23. http://dx.doi.org/10.1159/000067818CrossrefGoogle Scholar

  • [7] Steinhoff M, Ständer S, Seeliger S, Ansel JC, Schmelz M, Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol. 2003; 139:1479–1488. http://dx.doi.org/10.1001/archderm.139.11.1479CrossrefGoogle Scholar

  • [8] Esteves Junior I, Ferreira LM, Liebano RE. Peptídeo relacionado ao gene da calcitonina por iontoforese na viabilidade de retalho cutâneo randômico em ratos [Calcitonin gene-related peptide by iontophoresis on the viability of the randon skin flaps in rats]. Acta Cir Bras. 2004; 19:626–629. http://dx.doi.org/10.1590/S0102-86502004000600008CrossrefGoogle Scholar

  • [9] Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol. 1995; 33:482–496. http://dx.doi.org/10.1016/0190-9622(95)91395-5CrossrefGoogle Scholar

  • [10] Hagner S, Haberberger RV, Overkamp D, Hoffmann R, Voigt KH, McGregor GP. Expression and distribution of calcitonin receptor-like receptor in human hairy skin. Peptides. 2002; 23:109–116. http://dx.doi.org/10.1016/S0196-9781(01)00586-1CrossrefGoogle Scholar

  • [11] Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982; 298:240–244. http://dx.doi.org/10.1038/298240a0CrossrefGoogle Scholar

  • [12] Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983; 304:129–135. http://dx.doi.org/10.1038/304129a0CrossrefGoogle Scholar

  • [13] Amara SG, Evans RM, Rosenfeld MG. Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol. 1984; 4:2151–2160. CrossrefGoogle Scholar

  • [14] Goodman EC, Iversen LL. Calcitonin gene-related peptide: novel neuropeptide. Life Sci. 1986; 38:2169–2178. http://dx.doi.org/10.1016/0024-3205(86)90568-0CrossrefGoogle Scholar

  • [15] Breimer LH, MacIntyre I, Zaidi M. Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J. 1988; 255:377–390. Google Scholar

  • [16] Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004; 84:903–934. http://dx.doi.org/10.1152/physrev.00037.2003CrossrefGoogle Scholar

  • [17] Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol. 2006; 126:1937–1947. http://dx.doi.org/10.1038/sj.jid.5700429CrossrefGoogle Scholar

  • [18] Kakizoe E, Kobayashi Y, Gonda T, Shimoura K, Hattori K, Okunishi H. Synergistic interactions between neuropeptide and histamine on the capillary permeability in rat skin: evaluation by reflectance spectrophotometry. Microvasc Res. 1997; 54:27–34. http://dx.doi.org/10.1006/mvre.1997.2017CrossrefGoogle Scholar

  • [19] Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000; 21:457–487. Google Scholar

  • [20] Sleijffers A, Herreilers M, van Loveren H, Garssen J. Ultraviolet B radiation induces upregulation of calcitonin gene-related peptide levels in human Finn chamber skin samples. J Photochem Photobiol B. 2003; 69:149–152. http://dx.doi.org/10.1016/S1011-1344(03)00002-2CrossrefGoogle Scholar

  • [21] Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiationinduced immunosuppression. Methods. 2002; 28:97–103. http://dx.doi.org/10.1016/S1046-2023(02)00214-1CrossrefGoogle Scholar

  • [22] Seike M, Ikeda M, Morimoto A, Matsumoto M, Kodama H. Increased synthesis of calcitonin generelated peptide stimulates keratinocyte proliferation in murine UVB-irradiated skin. J Dermatol Sci. 2002; 28:135–143. http://dx.doi.org/10.1016/S0923-1811(01)00155-4CrossrefGoogle Scholar

  • [23] Sakuta H, Inaba K, Muramatsu S. Calcitonin generelated peptide enhances cytokine-induced IL-6 production by fibroblasts. Cell Immunol. 1995; 165(1):20–25. http://dx.doi.org/10.1006/cimm.1995.1182CrossrefGoogle Scholar

  • [24] V Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931;72(1):74–87. Google Scholar

  • [25] Johansson A, Holmgren S, Conlon JM. The primary structures and myotropic activities of two tachykinins isolated from the African clawed frog, Xenopus laevis. Regul Pept. 2002; 108:113–121. http://dx.doi.org/10.1016/S0167-0115(02)00154-4CrossrefGoogle Scholar

  • [26] Patacchini R, Lecci A, Holzer P, Maggi CA. Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci. 2004; 25:1–3. http://dx.doi.org/10.1016/j.tips.2003.11.005CrossrefGoogle Scholar

  • [27] Nawa H, Kotani H, Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984; 312:729–734. http://dx.doi.org/10.1038/312729a0CrossrefGoogle Scholar

  • [28] Schmelz M, Petersen LJ. Neurogenic inflammation in human and rodent skin. News Physiol Sci. 2001; 16:33–37. Google Scholar

  • [29] Cappugi P, Tsampau D, Lotti T. Substance P provokes cutaneous erythema and edema through a histamine-independent pathway. Int J Dermatol. 1992; 31:206–209. http://dx.doi.org/10.1111/j.1365-4362.1992.tb03938.xCrossrefGoogle Scholar

  • [30] Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 1985; 315:61–63. http://dx.doi.org/10.1038/315061a0CrossrefGoogle Scholar

  • [31] Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol. 1988; 90:399–401. http://dx.doi.org/10.1111/1523-1747.ep12456487CrossrefGoogle Scholar

  • [32] Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol. 1998; 7:81–96. http://dx.doi.org/10.1111/j.1600-0625.1998.tb00307.xCrossrefGoogle Scholar

  • [33] Okabe T, Hide M, Koro O, Yamamoto S. Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase. Eur J Pharmacol. 2000; 398:309–315. http://dx.doi.org/10.1016/S0014-2999(00)00304-6CrossrefGoogle Scholar

  • [34] Takahashi K, Nakanishi S, Imamura S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol. 1993; 101:646–651. http://dx.doi.org/10.1111/1523-1747.ep12371670CrossrefGoogle Scholar

  • [35] Kakurai M, Fujita N, Kiyosawa T, Inoue T, Ishibashi S, Furukawa Y, Demitsu T, Nakagawa H. Vasoactive intestinal peptide and cytokines enhance stem cell factor production from epidermal keratinocytes DJM-1. J Invest Dermatol. 2002; 119:1183–1188. http://dx.doi.org/10.1046/j.1523-1747.2002.19506.xCrossrefGoogle Scholar

  • [36] Albertin G, Carraro G, Parnigotto PP, Conconi MT, Ziolkowska A, Malendowicz LK, Nussdorfer GG. Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int J Mol Med. 2003; 11:635–639. Google Scholar

  • [37] Yule KA, White SR. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. Exp Lung Res. 1999; 25(3):261–273. http://dx.doi.org/10.1080/019021499270303CrossrefGoogle Scholar

  • [38] Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992; 49:693–698. http://dx.doi.org/10.1016/0306-4522(92)90237-VCrossrefGoogle Scholar

  • [39] Amann R, Sirinathsinghji DJ, Donnerer J, Liebmann I, Schuligoi R. Stimulation by nerve growth factor of neuropeptide synthesis in the adult rat in vivo: bilateral response to unilateral intraplantar injections. Neurosci Lett. 1996; 203:171–174. http://dx.doi.org/10.1016/0304-3940(95)12287-7CrossrefGoogle Scholar

  • [40] Amann R, Egger T, Schuligoi R. The tachykinin NK(1) receptor antagonist SR140333 prevents the increase of nerve growth factor in rat paw skin induced by substance P or neurogenic inflammation. Neuroscience. 2000; 100:611–615. http://dx.doi.org/10.1016/S0306-4522(00)00315-8CrossrefGoogle Scholar

  • [41] Wallengren J. Vasoactive peptides in the skin. J Investig Dermatol Symp Proc. 1997; 2:49–55. http://dx.doi.org/10.1038/jidsymp.1997.11CrossrefGoogle Scholar

  • [42] Wu H, Guan C, Qin X, Xiang Y, Qi M, Luo Z, Zhang C. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation. Pulm Pharmacol Ther. 2007; 20:513–524. http://dx.doi.org/10.1016/j.pupt.2006.04.002CrossrefGoogle Scholar

  • [43] Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc. 1997; 2:76–81. http://dx.doi.org/10.1038/jidsymp.1997.15CrossrefGoogle Scholar

  • [44] Sauerstein K, Klede M, Hilliges M, Schmelz M. Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin. J Physiol. 2000; 529:803–810. http://dx.doi.org/10.1111/j.1469-7793.2000.00803.xCrossrefGoogle Scholar

  • [45] Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses. 2008; 71:32–38. http://dx.doi.org/10.1016/j.mehy.2008.01.032CrossrefGoogle Scholar

  • [46] Hochman B, Nahas FX, Sobral CS, Arias V, Locali RF, Juliano Y, Ferreira LM. Nerve fibres: a possible role in keloid pathogenesis. Br J Dermatol. 2008; 158:651–652. http://dx.doi.org/10.1111/j.1365-2133.2007.08401.xCrossrefGoogle Scholar

  • [47] Ferreira LM, Gragnani A, Furtado F, Hochman B. Control of the skin scarring response. An Acad Bras Cienc. 2009; 81:623–629. http://dx.doi.org/10.1590/S0001-37652009000300024CrossrefGoogle Scholar

  • [48] Stelnicki EJ, Doolabh V, Lee S, Levis C, Baumann FG, Longaker MT, Mackinnon S. Nerve dependency in scarless fetal wound healing. Plast Reconstr Surg. 2000; 105:140–147. http://dx.doi.org/10.1097/00006534-200001000-00024CrossrefGoogle Scholar

  • [49] Tucci-Viegas VM, Hochman B, Franca JP, Ferreira LM. Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions. Int Wound J. 2010; 7:339–348. http://dx.doi.org/10.1111/j.1742-481X.2010.00698.xCrossrefGoogle Scholar

  • [50] Kiss M, Kemény L, Gyulai R, Michel G, Husz S, Kovács R, Dobozy A, Ruzicka T. Effects of the neuropeptides substance P, calcitonin gene-related peptide and alpha-melanocyte-stimulating hormone on the IL-8/IL-8 receptor system in a cultured human keratinocyte cell line and dermal fibroblasts. Inflammation. 1999; 23:557–567. http://dx.doi.org/10.1023/A:1020294507767CrossrefGoogle Scholar

  • [51] Kähler CM, Herold M, Wiedermann CJ. Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiol. 1993; 156:579–587. http://dx.doi.org/10.1002/jcp.1041560318CrossrefGoogle Scholar

  • [52] Kähler CM, Sitte BA, Reinisch N, Wiedermann CJ. Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol. 1993; 249:281–286. http://dx.doi.org/10.1016/0014-2999(93)90523-KCrossrefGoogle Scholar

  • [53] Parenti A, Amerini S, Ledda F, Maggi CA, Ziche M. The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol. 1996; 353:475–481. http://dx.doi.org/10.1007/BF00169165CrossrefGoogle Scholar

  • [54] Bae SJ, Matsunaga Y, Takenaka M, Tanaka Y, Hamazaki Y, Shimizu K, Katayama I. Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts. Int Arch Allergy Immunol. 2002; 127:316–321. http://dx.doi.org/10.1159/000057749CrossrefGoogle Scholar

  • [55] Liu JY, Hu JH, Zhu QG, Li FQ, Sun HJ. Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol. 2006; 155:657–662. http://dx.doi.org/10.1111/j.1365-2133.2006.07408.xCrossrefGoogle Scholar

  • [56] Kähler CM, Herold M, Reinisch N, Wiedermann CJ. Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol. 1996; 166:601–608. http://dx.doi.org/10.1002/(SICI)1097-4652(199603)166:3<601::AID-JCP15>3.0.CO;2-9CrossrefGoogle Scholar

  • [57] Hu D, Chen B, Zhu X, Tao K, Tang C, Wang J. Substance P up-regulates the TGF-beta 1 mRNA expression of human dermal fibroblasts in vitro. Zhonghua Zheng Xing Wai Ke Za Zhi. 2002; 18:234–236. Google Scholar

  • [58] Morbidelli L, Maggi CA, Ziche M. Effect of selective tachykinin receptor antagonists on the growth of human skin fibroblasts. Neuropeptides. 1993; 24:335–341. http://dx.doi.org/10.1016/0143-4179(93)90004-TCrossrefGoogle Scholar

  • [59] Xie L, Takahara M, Nakahara T, Oba J, Uchi H, Takeuchi S, Moroi Y, Furue M. CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance P. Arch Dermatol Res. 2011;303(1):49–55. http://dx.doi.org/10.1007/s00403-010-1093-9Google Scholar

  • [60] Liu JY, Hu JH, Zhu QG, Li FQ, Wang J, Sun HJ. Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol. 2007; 7(6):816–823. http://dx.doi.org/10.1016/j.intimp.2007.02.003CrossrefGoogle Scholar

  • [61] Liu JY, Zhao YZ, Peng C, Li FQ, Zhu QG, Hu JH. Effect of cetirizine hydrochloride on the expression of substance P receptor and cytokines production in human epidermal keratinocytes and dermal fibroblasts. Yao Xue Xue Bao. 2008;43(4):383–387. Google Scholar

  • [62] Olerud JE, Usui ML, Seckin D, Chiu DS, Haycox CL, Song IS, Ansel JC, Bunnett NW. Neutral endopeptidase expression and distribution in human skin and wounds. J Invest Dermatol. 1999; 112:873–881. http://dx.doi.org/10.1046/j.1523-1747.1999.00596.xCrossrefGoogle Scholar

  • [63] McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998; 393:333–339. http://dx.doi.org/10.1038/30666CrossrefGoogle Scholar

  • [64] Husmann K, Sexton PM, Fischer JA, Born W. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function. Mol Cell Endocrinol. 2000; 162:35–43. http://dx.doi.org/10.1016/S0303-7207(00)00212-4CrossrefGoogle Scholar

  • [65] Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, Smith DM. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol. 2000; 130:189–195. http://dx.doi.org/10.1038/sj.bjp.0702975CrossrefGoogle Scholar

  • [66] Bailey RJ, Hay DL. Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides. 2006; 27:1367–1375. http://dx.doi.org/10.1016/j.peptides.2005.11.014Google Scholar

  • [67] Choksi T, Hay DL, Legon S, Poyner DR, Hagner S, Bloom SR, Smith DM. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. Br J Pharmacol. 2002; 136:784–792. http://dx.doi.org/10.1038/sj.bjp.0704761CrossrefGoogle Scholar

  • [68] Withers DJ, Coppock HA, Seufferlein T, Smith DM, Bloom SR, Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 1996; 378:83–87. http://dx.doi.org/10.1016/0014-5793(95)01427-6CrossrefGoogle Scholar

  • [69] Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem. 2000; 275(40):31438–31443. http://dx.doi.org/10.1074/jbc.M005604200CrossrefGoogle Scholar

About the article

Published Online: 2014-04-30

Published in Print: 2014-07-01

Citation Information: Open Life Sciences, Volume 9, Issue 7, Pages 717–726, ISSN (Online) 2391-5412, DOI: https://doi.org/10.2478/s11535-014-0301-6.

Export Citation

© 2014 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Tamara Mengoni, Manuela Adrian, Susana Pereira, Beatriz Santos-Carballal, Mathias Kaiser, and Francisco Goycoolea
Pharmaceutics, 2017, Volume 9, Number 4, Page 56

Comments (0)

Please log in or register to comment.
Log in